Chinese Medical E-ournals Database

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2013, Vol. 09 ›› Issue (01): 113 -116. doi: 10.3877/cma.j.issn.1673-5250.2013.01.031

Special Issue:

Review

Progress Research of Etiopathogenisis and Prediction of Early-Onset Pre-Eclampsia

Ya-ling FENG1(), Qian XU1, Jing-ying XIANG1   

  1. 1. Department of Obstetrics, Wuxi Matemal and Child Health Hospital Affiliated to Nanjing Medical University, Wuxi 214002, Jiangsu Province, China
  • Received:2012-10-08 Revised:2013-01-05 Published:2013-02-01
  • Corresponding author: Ya-ling FENG
  • About author:
    Corresponding author: FENG Ya-ling, Email:

Etiopathogenisis of early-onset pre-eclampsia involves predisposing genes polymorphism, placental coytokine dysfunction and immunological disorder. The patitent history, maternal peripheral blood correlation protein detection and color Doppler flow imaging (CDFI) may contribute to predict early-onset pre-eclampsia. This paper discusses the progress of recent studies in early-onset pre-eclampsia.

[1]
Vaisbuch E, Romero R, Mazak-iTovi S, et al. Retinol binding protein 4-a novel association with early-onset preeclampsia[J]. J Perinat Med, 2010, 38:129-139.
[2]
Ma RQ, Sun MN, Yang Z. Effects of preeclampsia-like symptoms at early gestational stage on feto-placental outcomes in a mouse model[J]. Chin Med J (Eng), 2010, 123:707-712.
[3]
Yang Z, Wang JL, Huang P, et al. Study on unparalleled damage of end organs in severe preeclampsia and perinatal outcomes[J]. Chin J Perinat Med, 2006, 91:10-14.
[4]
Jenkins SM, Head BB, Hauth JC. Severe preeclampsia at <25 weeks of gestation: Maternal and neonatal outcomes[J]. Am J Obstet Gynecol, 2002, 186(4):790-795.
[5]
Hall DR, Odendaal HJ, Steyn DW, et al. Expectant management of early onset severe preeclampsia: Maternal outcome[J]. BJOG, 2000, 107(10):1252-1257.
[6]
Chesley L, Copper DW. Genetics of hypertension in pregnancy: Possible single gene control of pre-eclampsia and eclampsia in the descendants of eclamptic women[J]. Br J Obstet Gynecol, 1986, 93:898-908.
[7]
Esplin MS, Fausett MB, Fraser A, et al. Paternal and maternal components of the predisposition to pre-eclampsia[J]. N Engl J Med, 2001, 344:867-876.
[8]
Haddad T. Update on pre-eclampsia[J]. Int Anesthesiol Clin, 2002, 40:115-135.
[9]
Junus K, Centlow M, Wikstrom AK, et al. Gene expression profiling of placentae from women with early- and late-onset pre-eclampsia: Down-regulation of the angiogenesis-related genes ACVRL1 and EGFL7 in early-onset disease[J]. Mol Hum Reprod, 2012, 18(3):146-155.
[10]
Lee T, Sumpio BE. Cell signalling in vascular cells exposed to cyclic strain: The emerging role of protein phosphatases[J]. Biotechnol Applochen, 2004, 39(pt2):129-139.
[11]
Aubard Y, Darodes N, Cantaloube M. Hyperhomocysteinemia and pregnancy review of our present understanding and therapeutic implications[J]. Eur J Obstet Gynecol Reprod Biol, 2000, 93(2):157-158.
[12]
Kanayama N. Trophoblastic injury: New etiological and pathological concept of preeclampsia[J]. Croat Med J, 2003, 44(2):148-156.
[13]
Chafet Z, Kuhnreich I, Sammar M, et al. First-trimester placental protein 13 screening for preeclampsia and intrauterine grow threstriction[J]. Am J Obstet Gynecol, 2007, 197(1):35, e1-7.
[14]
Sekizawa A, Sekizawa A, Purwosunu Y, et al. PP13 mRNA expression intropho-blasts from preeclamptic placentas[J]. Reprod Sci, 2009, 16(4):408-413.
[15]
Knox PG, Milner AE, Green NG, et al. Inhibition of metalloprotenase cleavage enhances the cytotoxicity of Fas Ligand[J]. J Immunol, 2003, 170(2):677-685.
[16]
Jongbloet PH. Offspring sex ratio at population level versus early and late onset preeclampsia[J]. Early Hum Dev, 2004, 79(2):159-163.
[17]
Shenhav S, Gemer O, Sassoon E, et al. Mid-trimester tripletest levels in early and late onset severe pre-eclampsia[J]. Prenat Diagn, 2002, 22(7):579-582.
[18]
Qi HB. Prediction of preeclampsia[J]. Chin J Obstet Gynecol Pediatr: Electron Ed, 2011, 7(3):194-196.
[19]
Nanjundan P, Bagga R, Kalra JK, et al. Risk factors for early onset severe pre-eclampsia and eclampsia among north Indian women[J]. Obstet Gynaecol, 2011, 31(5):384-389.
[20]
Cruz-Martinez R, Figueras F. The role of Doppler and placental screening[J]. Best Pract Res Clin Obstet Gynaecol, 2009, 23(6):845-855.
[21]
Baumann MU, Bersinger NA, Mohaupt MG, et al. First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia[J]. Am J Obstet Gynecol, 2008, 199(3):266. e1-6.
[22]
Kusanovic JP, Romero R, Chaiworapongsa T, et al. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia[J]. J Matern Fetal Neonatal Med, 2009, 22(11):1021-1038.
[23]
Masoura S, Kalogiannidis IA, Gitas G, et al. Biomarkers in pre-eclampsia: A novel approach to early detection of the disease[J]. J Obstet Gynaecol, 2012, 32(7):609-616.
[24]
Vandenberghe G, Mensink I, Twisk JW, et al. First trimester screening for intra-uterine growth restriction and early-onset pre-eclampsia[J]. Prenat Diagn, 2011, 31(10):955-961.
[25]
Chafetz I, Kuhnreich I, Sammar M, et al. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction[J]. Am J Obstet Gynecol, 2007, 197(1):35. e1-7.
[26]
Romero R, Kusanovic JP, Than NG, et al. First-trimester maternal serum PP13 in the risk assessment for preeclampsia[J]. Am J Obstet Gynecol, 2008, 199(2):122.e1-122.e11.
[27]
Akolekar R, Syngelaki A, Beta J, et al. Maternal serum placental protein 13 at 11- 13 weeks of gestation in preeclampsia[J]. Prenat Diagn, 2009, 29(12):1103-1108.
[28]
Cowans NJ, Spencer K, Meiri H. First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes[J]. Prenat Diagn, 2008, 28(2):121-125.
[1] Yan Zhuang, Linfeng Dai, Haidong Zhang, Qiuhua Chen, Qingfang Nie. Risk factors of early survival for sepsis patients and construction of a Cox risk prediction model[J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2024, 17(05): 372-378.
[2] Xialin Li, Fang He. Risk assessment and early warning system for postpartum hemorrhage[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 498-503.
[3] Xiaoling Tie, Yi Liu, Ying Yang, Fengyu Che. Clinical features and genetic analysis of Rubinstein-Taybi syndrome:three cases report and literature review[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(04): 452-459.
[4] Hongchu Huang, Meirong Huang, Lihong Wen. Risk factor analysis and risk prediction model of granulocytopenia infection after chemotherapy in patients with hematological malignancies[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2024, 18(05): 285-292.
[5] Ling Xi, Hanwen Tong, Ji Miao, Yonghuan Mao, Xiaofei Shen, Junfeng Du, Ye Liu. Risk factors prediction model of parastostomy hernia based on sarcopenia[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(01): 48-51.
[6] Qinfang Qu, Fanglian Shu. Influencing factors of stress urinary incontinence in patients with pelvic organ prolapse after pelvic floor reconstruction and construction of nomogram prediction model[J]. Chinese Journal of Endourology(Electronic Edition), 2024, 18(06): 606-612.
[7] Lu Jiang, Ju Zhou, Yang Mao, Qian Dai. Comprehensive analysis of single-cell and bulk RNA sequencing for predicting prognosis and treatment response in lung squamous cell carcinoma[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2024, 17(04): 535-542.
[8] Yu Gong, Yuan Liao, Mei Shang. Influencing factors and prediction model for recurrence of hepatocellular carcinoma after TACE[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 818-824.
[9] Han Sun, Bing Yu, Xia Wu, Xilang Zhou. Construction and validation of a predictive model for screening of colorectal cancer based on circulating tumor DNA methylation[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(06): 500-506.
[10] Xiangqing Qin, Chen Zhu, Haiyin Zhang. Construction of a normogram model for predicting the risk of esophageal and gastric varices bleeding in cirrhosis[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(04): 330-335.
[11] Na Tian, Feitian Han. Establishment of a model for predicting the recurrence of acute pancreatitis based on CT plain scan imaging group model and systemic immune inflammatory index[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(04): 355-359.
[12] Zhan Wang, Wenkun Li, Yi Yang, Fang Xu, Minsi Zhou, Jiayi Su, Yadan Wang, Jing Wu. Application of inflammatory markers in early-onset colorectal tumors[J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(09): 802-810.
[13] Qiaoling Wei, Yan Huang, Chang Zhao, Qingfeng Song, Zuyi Chen, Ying Huang, Chang Meng, Jing Huang. Construction and verification of moderate to severe pain risk prediction model after microwave ablation of liver cancer[J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(08): 715-721.
[14] Xiaowen Cai, Huijing Li, Jie Qiu, Yifan Yang, Suxian Wu, Yutong Lin, Qiuna He. Construction and verification of a pain risk prediction model for patients with liver cancer after TACE[J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(08): 722-728.
[15] Shengkai Huang, Bin Xu, Jian Su, Long Sun. Time series analysis of hepatitis B epidemic trend in Hainan Province from 2010 to 2020 and establishment of a model for prediction of hepatitis B epidemic incidence from 2021 to 2030[J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(06): 555-561.
Viewed
Full text


Abstract